https://www.selleckchem.com/pr....oducts/lificiguat-yc
To characterize longitudinal symptoms of mild coronavirus disease 2019 (COVID-19) patients for a period of 6months, to potentially aid in disease management. Phone interviews were conducted with 103 patients with mild COVID-19 in Israel over a 6-month period (April 2020 to October 202. Patients were recruited via social media and word to mouth and were interviewed up to 4 times, depending on reports of their unresolved symptoms. Inclusion criteria required participants to be residents of Israel aged 18years or older, with posi
Like
Comment
Share
